Project Grant R03AG080082

Award Date 4/15/23
Completion Date 3/31/25
Dollars Obligated $181K
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10017, USA
Similar Awards
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
This $917,701 federal Project Grant award under the National Institute on Aging's Aging Research program (CFDA 93.866) will fund a 5-year study conducted by Brigham & Women's Hospital to implement and evaluate an Acute Hospital Care at Home (AHCAH) pathway specifically for people living with dementia. The study aims to: 1) Evaluate the effect of a pre-enrollment AHCAH pathway on quality of life over 12 months for persons with moderate to severe dementia (Aim 1); and 2) Evaluate the...
The Project Grant award R01AG087243, funded by the National Institute on Aging (NIA) under the Aging Research (CFDA 93.866) Federal Grant Program, aims to illuminate the role of fragmented ambulatory care in the diagnosis and care of people living with Alzheimer's disease and related dementias (ADRD). The $3,374,303 project, awarded on Sep 15, 2024, will involve: Secondary analyses of two NIA-funded cohort studies linked to claims data to determine if fragmentation is associated with delayed...
This Project Grant award, provided by the National Institute on Aging (CFDA 93.866 Aging Research), aims to examine the use of home-based medical care (HBMC) and telemedicine among individuals with Alzheimer's disease and related dementias (ADRD) enrolled in both public (fee-for-service) and private (Medicare Advantage) Medicare plans. The $2,054,062 award, effective September 15, 2024 through May 31, 2026, will utilize national Medicare administrative data from 2017-2023 to identify trends in...
The project, titled "Improving Incontinence Support for Family Caregivers and Persons Living with Dementia," is funded by a $246,000 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) with a start date of September 1, 2024 and an end date of June 30, 2026. The overarching objective of this project is to better understand the unique urinary incontinence (UI) support needs, preferences, and priorities of family caregivers of persons living with...
This $121,209 National Institute on Aging project grant will support research assessing the impact of primary care structural capabilities on hospitalizations among older adults with dementia. Specifically, the grantee will analyze cross-sectional data from 2018-2019 to describe structural capabilities like care coordination, electronic health records, and community integration in primary care practices employing nurse practitioners to serve Medicare beneficiaries with Alzheimer's disease and...
The University of Rochester received a $1,092,079 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) to study the impacts of informal family caregiving on nursing home residents with Alzheimer's disease and related dementias (ADRD), as well as the associations between state Essential Caregiver (EC) programs and caregiving outcomes during the COVID-19 pandemic. The project aims to determine how family caregiving affects the health of nursing home residents...
This $243,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a 5-year study to address the issue of potentially inappropriate medication (PIM) use among older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care. The key objectives are to: 1) Identify factors and barriers/facilitators associated with routine PIM deprescribing practices for ADRD patients in home health care, using a mixed methods approach; and...
The National Institute on Aging (NIA) awarded a $1,928,657 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the Regents of the University of Michigan, doing business as the University of Michigan. The 3-year project aims to develop and evaluate new measures of family availability to provide care for people living with Alzheimer's disease and related dementias (ADRD). The study will leverage national survey data to: 1) Create sub-indices and a composite measure of...

EFFECTS OF FAMILY CAREGIVER AVAILABILITY AND CAPACITY ON HOME HEALTH CARE FOR OLDER ADULTS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS - PROJECT SUMMARY/ABSTRACT OF AN ESTIMATED 5.4 MILLION OLDER ADULTS WITH ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (ADRD) IN THE US, 67% RESIDE IN THE COMMUNITY WITH UNIQUE AND SIGNIFICANT CARE NEEDS. MEDICARE-FUNDED HOME HEALTH (HH) DELIVERS SKILLED NURSING, THERAPY, AND PERSONAL CARE AIDE SERVICES IN THE PATIENT'S HOME AND IS ONE OF FEW AFFORDABLE AND ACCESSIBLE OPTIONS FOR HOME-BASED CARE AMONG THOSE WITH ADRD. OF THE 3.4 MILLION MEDICARE BENEFICIARIES WHO ACCESS HH EACH YEAR, 31% HAVE ADRD. HH PATIENTS WITH ADRD RECEIVE MORE INTENSIVE CARE, YET ARE MORE LIKELY TO EXPERIENCE ADVERSE OUTCOMES INCLUDING INSTITUTIONALIZATION AND HOSPITALIZATION. THUS, THERE IS CRITICAL NEED TO DEVELOP TAILORED HH INTERVENTIONS TO IMPROVE OUTCOMES FOR PATIENTS WITH ADRD. IN 87% OF HH EPISODES, CLINICIANS REPORT NEEDING FAMILY CAREGIVER ASSISTANCE TO IMPLEMENT THE PLAN OF CARE AND ENGAGING/SUPPORTING FAMILY CAREGIVERS DURING HH CONTRIBUTES TO IMPROVED CARE OUTCOMES-INCLUDING REDUCED READMISSION RISK AND GREATER PATIENT AND FAMILY SATISFACTION. FAMILY CAREGIVERS ARE A CRUCIAL RESOURCE FOR THOSE WITH ADRD, INCLUDING DURING HH. HOWEVER, THERE IS CURRENTLY A DEARTH OF INFORMATION REGARDING ADRD FAMILY CAREGIVERS' SPECIFIC ROLES AND SUPPORT NEEDS DURING HH. ANALYSES OF ADRD CAREGIVER INVOLVEMENT IN CARE DELIVERY HAVE FOCUSED ON THE AMBULATORY SETTING AND HOLD LIMITED APPLICABILITY FOR HH DUE TO THIS SETTING'S UNIQUE PAYMENT AND CARE DELIVERY STRUCTURES. PRIOR WORK EXAMINING CAREGIVER ACTIVITIES AND TRAINING NEEDS DURING HH DID NOT SPECIFICALLY EXAMINE THOSE WITH ADRD. HH PATIENTS WITH ADRD (AND THEIR CAREGIVERS) MERIT TARGETED STUDY GIVEN: THE UNIQUE CHALLENGES OF ADRD CAREGIVING, ADRD PATIENTS' HIGHER RISK FOR ADVERSE HH OUTCOMES, AND PRIOR WORK INDICATING THAT CAREGIVERS ARE MORE LIKELY TO NEED TRAINING DURING HH IF ASSISTING A PATIENT WITH COGNITIVE IMPAIRMENT. THE GOAL OF THIS PROJECT IS TO DESCRIBE ADRD CAREGIVERS' ROLE AND TRAINING NEEDS DURING HH, AND TO DETERMINE HOW CAREGIVER AVAILABILITY AND CAPACITY IMPACT HH CARE DELIVERY AND OUTCOMES FOR PATIENTS WITH ADRD. AVAILABILITY REFERS TO CAREGIVERS' WILLINGNESS TO ASSIST AND HOW OFTEN THEY ARE PRESENT IN THE HOME. CAPACITY REFERS TO CAREGIVERS' IDENTIFIED TRAINING NEEDS RELATED TO SPECIFIC CAREGIVING ACTIVITIES. WE WILL USE A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES WITH DIAGNOSED ADRD (DETERMINED VIA MEDICARE CLAIMS) WHO RECEIVED HH IN 2018. WE WILL ANALYZE LINKED HH PATIENT ASSESSMENT, MEDICARE CLAIMS, AND HH AGENCY ADMINISTRATIVE DATA FOR THIS SAMPLE TO 1) CHARACTERIZE CAREGIVER INVOLVEMENT (INCLUDING TYPES OF ASSISTANCE PROVIDED, AVAILABILITY, AND CAPACITY) DURING HH; 2) DETERMINE THE IMPACT OF CAREGIVER AVAILABILITY AND CAPACITY ON HH CARE DELIVERY FOR PATIENTS WITH ADRD; AND 3) ASSESS THE IMPACT OF CAREGIVER AVAILABILITY AND CAPACITY ON HH OUTCOMES FOR PATIENTS WITH ADRD. FINDINGS WILL PROVIDE NOVEL FOUNDATIONAL EVIDENCE REGARDING ADRD CAREGIVERS' ROLE AND SUPPORT NEEDS DURING HH, INFORMING THE DEVELOPMENT OF TARGETED INTERVENTIONS TO IMPROVE CARE FOR HH PATIENTS WITH ADRD BY BETTER ENGAGING AND SUPPORTING THEIR FAMILY CAREGIVERS.

Posted 4/10/23, 12:00 AM